Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by HC Thurm
Clinical Trial Simulations Based on a Meta-Analysis of Studies in Patients With Locally Advanced and/or Metastatic Adenocarcinoma Pancreatic Cancer Receiving Gemcitabine (GEM) Alone or in Combination
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Effect of Clinical Status on Survival in Patients With Borderline or Locally Advanced Pancreatic Adenocarcinoma
World Journal of Surgical Oncology
Surgery
Oncology
Phase II Trial of Vatalanib in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma After First-Line Gemcitabine Therapy (PCRT O4-001)
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
NeoadjuvantNab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX
Anticancer Research
Medicine
Cancer Research
Oncology
A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine for Patients With Advanced Pancreatic Cancer
Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer Research
Allergy
Immunology
Pharmacology
A Multicentre Randomised Phase II Trial of Gemcitabine Alone vs Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: GEMSAP Study
British Journal of Cancer
Cancer Research
Oncology
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients With FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review
Cancers
Cancer Research
Oncology
Phase I Dose-Escalation Study of Copanlisib in Combination With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer
British Journal of Cancer
Cancer Research
Oncology
Design of RESILIENCE: A Phase 3 Trial Comparing Capecitabine in Combination With Sorafenib or Placebo for Treatment of Locally Advanced or Metastatic HER2-negative Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
